Andy Martin
Advertisement
Articles by Andy Martin
The ICH hopes to avoid detrimental impacts of variability such as delays in medicine availability and the launch of new products, and different approaches to compliance inspections.
Advertisement
Latest Updated Articles
- Industry consults on new regulations
Published: January 1st 2007 | Updated:
- New regulation of children's medicines
Published: March 1st 2007 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Launches PreCheck Pilot Program to Bolster Domestic Drug Manufacturing
2
Women in STEM: Cultivating Scientific Confidence
3
Cellares Scales IDMO Model for Gene-Edited Stem Cells Therapies
4
Behind the Headlines Episode 32: AI’s Power, NVIDIA & Lilly, Revolution Medicine
5